Background <p>Psychiatric comorbidity among adolescents meeting diagnostic criteria for substance use disorder (SUD) and/or alcohol use disorder (AUD) is poorly characterised in sub-Saharan African settings. Existing approaches typically quantify co-occurring diagnoses individually rather than identifying distinct configurations of psychiatric burden. The present study applied latent class analysis (LCA) to delineate comorbidity profiles within a substance-affected Nigerian adolescent sample and examined associations between class membership, suicidality, cumulative adversity, and functional impairment.</p> Methods <p>Cross-sectional analysis of 614 adolescents meeting DSM-IV criteria for SUD and/or AUD, drawn from the Lagos Schools Emotional and Behavioral Health Survey (LSEBHS), a population-based survey of 9,437 public secondary school students across 47 schools in Lagos State, Nigeria. Latent class analysis was conducted using five binary psychiatric indicators: major depressive disorder (MDD), any anxiety disorder, conduct disorder, attention-deficit/hyperactivity disorder (ADHD), and psychotic-like experiences (PLE; ≥6 items on the Prodromal Questionnaire-16). Multinomial logistic regression (R3STEP) adjusted for classification uncertainty. All analyses incorporated complex survey sampling weights.</p> Results <p>A three-class solution was retained as optimal (BIC = 2,856.8; entropy = 0.87; all classes ≥ 18.0%). The Low Psychiatric Burden class (48.0%, <i>n</i> ≈ 295) showed uniformly low indicator probabilities. The Internalising-PLE class (34.0%, <i>n</i> ≈ 209) was characterised by elevated MDD (0.74), anxiety (0.68), and PLE (0.61) probabilities. The High Multimorbidity class (18.0%, <i>n</i> ≈ 110) showed high probabilities across all five indicators (MDD 0.91; anxiety 0.84; PLE 0.88; conduct disorder 0.74; ADHD 0.67). Overall, 80.1% of the sample met criteria for at least one co-occurring psychiatric disorder. Past-month suicidal ideation increased monotonically across classes (Low Burden: 3.8%; Internalising-PLE: 11.2%; High Multimorbidity: 18.4%). High cumulative adversity (ACE ≥ 3) was the strongest independent predictor of High Multimorbidity class membership (AOR = 2.88; 95% CI 1.82–4.56). A proof-of-concept screening analysis yielded AUC = 0.79 within-model; against an independent functional impairment criterion, AUC was 0.72, with the 0.07 difference quantifying the circularity effect.</p> Conclusions <p>Psychiatric comorbidity among substance-affected Nigerian adolescents is heterogeneously distributed across three statistically distinct profiles. The High Multimorbidity stratum, comprising approximately one in five adolescents, is characterised by near-universal psychiatric burden, elevated suicidality, and strong associations with cumulative adversity. Longitudinal research is required to clarify developmental pathways and validate these profiles in independent samples.</p> Clinical trial number <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Latent class profiles of psychiatric comorbidity among substance-affected Nigerian adolescents: a population-based analysis

  • Abiodun O. Adewuya,
  • Olushola Olibamoyo,
  • Azizat Lebimoyo,
  • Olabisi E. Oladipo,
  • Arit Esangbedo

摘要

Background

Psychiatric comorbidity among adolescents meeting diagnostic criteria for substance use disorder (SUD) and/or alcohol use disorder (AUD) is poorly characterised in sub-Saharan African settings. Existing approaches typically quantify co-occurring diagnoses individually rather than identifying distinct configurations of psychiatric burden. The present study applied latent class analysis (LCA) to delineate comorbidity profiles within a substance-affected Nigerian adolescent sample and examined associations between class membership, suicidality, cumulative adversity, and functional impairment.

Methods

Cross-sectional analysis of 614 adolescents meeting DSM-IV criteria for SUD and/or AUD, drawn from the Lagos Schools Emotional and Behavioral Health Survey (LSEBHS), a population-based survey of 9,437 public secondary school students across 47 schools in Lagos State, Nigeria. Latent class analysis was conducted using five binary psychiatric indicators: major depressive disorder (MDD), any anxiety disorder, conduct disorder, attention-deficit/hyperactivity disorder (ADHD), and psychotic-like experiences (PLE; ≥6 items on the Prodromal Questionnaire-16). Multinomial logistic regression (R3STEP) adjusted for classification uncertainty. All analyses incorporated complex survey sampling weights.

Results

A three-class solution was retained as optimal (BIC = 2,856.8; entropy = 0.87; all classes ≥ 18.0%). The Low Psychiatric Burden class (48.0%, n ≈ 295) showed uniformly low indicator probabilities. The Internalising-PLE class (34.0%, n ≈ 209) was characterised by elevated MDD (0.74), anxiety (0.68), and PLE (0.61) probabilities. The High Multimorbidity class (18.0%, n ≈ 110) showed high probabilities across all five indicators (MDD 0.91; anxiety 0.84; PLE 0.88; conduct disorder 0.74; ADHD 0.67). Overall, 80.1% of the sample met criteria for at least one co-occurring psychiatric disorder. Past-month suicidal ideation increased monotonically across classes (Low Burden: 3.8%; Internalising-PLE: 11.2%; High Multimorbidity: 18.4%). High cumulative adversity (ACE ≥ 3) was the strongest independent predictor of High Multimorbidity class membership (AOR = 2.88; 95% CI 1.82–4.56). A proof-of-concept screening analysis yielded AUC = 0.79 within-model; against an independent functional impairment criterion, AUC was 0.72, with the 0.07 difference quantifying the circularity effect.

Conclusions

Psychiatric comorbidity among substance-affected Nigerian adolescents is heterogeneously distributed across three statistically distinct profiles. The High Multimorbidity stratum, comprising approximately one in five adolescents, is characterised by near-universal psychiatric burden, elevated suicidality, and strong associations with cumulative adversity. Longitudinal research is required to clarify developmental pathways and validate these profiles in independent samples.

Clinical trial number

Not applicable.